Participants 75 102 3
recurrent gastric carcinoma
Participants 232 247 3
cancer patients
Participants 371 418 6
group of patients with recurrent gastric cancer
Participants 482 722 6
1) Intradermal group (ID Group), 42 patients given an intradermal injections of OK-432. 2) Intramuscular group (IM Group), 40 patients given an intramuscular injections of OK-432. 3) Control group (C Group), 39 patients not given injections
